Why We Aren’t Seeing Many Big Cannabis Deals With Other Industries

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) still hasn’t found a beverage maker to partner up with, and landing a big fish may not be so easy.

| More on:
edit Jars of marijuana

Image source: Getty Images

Cannabis is still very polarizing for consumers and investors. While it presents a great opportunity, with it being a brand-new industry to get involved in, it also presents a risk, particularly for established companies. Branding is important, and if a company gets it wrong, it could risk alienating its existing consumers, which would be bad news for its stock.

Warren Buffett also alluded to that in a recent interview with Fox when discussing one of his investments, Coca-Cola, which he stated has “an awareness of a specific brand.” However, he didn’t say he would sell his shares in Coke if the company decided to get involved with the industry. Charlie Munger, meanwhile, said that the company has “a wholesome image and cannabis doesn’t.”

While the soft drink company doesn’t appear to have any interests right now in the cannabis industry, there were rumours of a possible deal with Coke and Aurora Cannabis (TSX:ACB)(NYSE:ACB).

It’s not clear if there was anything to the rumours and if Coke was legitimately interested or not, but if it had second thoughts, it wouldn’t be the only company to be concerned about the impact the industry would have had on its image.

Starbucks said it didn’t think the industry would be suitable for its brand, and I suspect many other big companies likely feel the same way. For some, it’s just not worth the risk, especially with the industry still being illegal federally and the opportunities being very limited.

While medical marijuana may be making progress in various parts of the world, there are still many skeptics and research on its effectiveness has still been limited thus far. It’s going to take a while before we see cannabis get legalized and likely even longer before it’s socially acceptable among the general population.

Although Aurora might be looking for a big company to partner up with, its options are certainly limited at this point. Until the U.S. market is entirely open for business, few companies are going to want to step into the cannabis industry, even if it will provide their sales with a boost.

Aurora has even more incentive to find a partner when it comes to beverages, especially with edibles due to be legalized in October and rival Canopy Growth already having a significant deal in place with Constellation Brands. However, it’s one of many cannabis companies that are looking for deals in what’s becoming a crowded industry.

Bottom line

Buffett and Munger offer more some valuable insight as to why deals are still few and far between for the cannabis industry. Their comments centred on the importance of branding and representing the company’s values rather than just sheer sales growth. These are two well-respected investors that know a lot about how successful businesses are run, and their comments are a reminder that more needs to be considered than just a company’s financials when investing.

A brand’s image is vital to its long-term success, and that’s why focusing on the health benefits of cannabis is going to be crucial for Aurora in finding a deal with a company from another industry.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. David Gardner owns shares of Starbucks. Tom Gardner owns shares of Starbucks. The Motley Fool owns shares of Starbucks. Starbucks is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »